NCT06666556 Bowel Preparation in Colonoscopy: Lactulose Vs Polyethyleneglycol, Randomized Double-blind Comparative Clinical Trial, Multicenter Study.
| NCT ID | NCT06666556 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Hospital Civil de Guadalajara |
| Condition | Colorectal Cancer Screening |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-07-20 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 300 participants in total. It began in 2024-07-20 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial it is to bowel the instestinal preparation with lactulose vs poliethylenglicol as better agent to have a quality colonoscopy and demostrate that lactulose is most efective, has a good tolerance and the patient would have a better satisfaction, so the question is: wich is the eficancy of lactulose in comparision with thepoliethylenglycol in the intestinal preparation for the colonoscopy?
Eligibility Criteria
* Inclusion Criteria: * Patients with indication for colonoscopy in our coloproctology service * Both women and men * Patients within an age range of 18-79 years * Patients who agree having a colonoscopy and who sign the informed consent to participate in the protocol Exclusion Criteria: * Patients under 18 or over 80 years old * All patients that won´t like to participate in the protocol or won´t sign the informed consent * Pregnant women * Patients with a medical record of colonic resection, ostomy status, severe cardiopulmonary and renal diseases, major psychiatric disorders, therapeutic colonoscopy or any contraindications for colonoscopy * Non compliance with the colonic preparation regimen * Active bleeding during the procedure * Patients with a known diagnosis of colorectal cancer
Contact & Investigator
Roberto U M. C. Roberto Ulises Cruz Neri (Master in Science, Medical Sta, M. C
✉ robertocruzneri@gmail.com📞 +52 3311946664
Frequently Asked Questions
Who can join the NCT06666556 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 79 Years, studying Colorectal Cancer Screening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06666556 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT06666556 currently recruiting?
Yes, NCT06666556 is actively recruiting participants. Contact the research team at robertocruzneri@gmail.com for enrollment information.
Where is the NCT06666556 trial being conducted?
This trial is being conducted at Guadalajara, Mexico, Guadalajara, Mexico, México, Mexico.
Who is sponsoring the NCT06666556 clinical trial?
NCT06666556 is sponsored by Hospital Civil de Guadalajara. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.